Reviewed by Sarah Alter, Ph.D. — Scientific Affairs, OrganaBio. 15 years of immunology research spanning autoimmunity, cancer, and infectious disease. University of Miami Miller School of Medicine. Registered Patent Agent.
Why Processing Time Is Not Just a Logistics Variable
Most biospecimen suppliers treat collection-to-processing time as a logistics detail. OrganaBio treats it as the primary quality determinant — and the data supports this position.
PBMCs are biologically active from the moment blood leaves the donor. Monocytes, platelets, and granulocytes in the collection begin releasing cytokines, activating T cells, and consuming the oxygen that lymphocytes need to survive. At 37°C, these processes accelerate. At room temperature, they slow but do not stop. The difference between a PBMC lot processed at 30 minutes and one processed at 4–6 hours is not a technical footnote — it is a measurable difference in monocyte composition, T cell activation state, and downstream functional assay results.
One study measuring monocyte composition as a function of post-collection processing time found that samples held at room temperature for 18 hours before processing showed a 70% reduction in classical monocyte (CD14++CD16−) recovery, with a corresponding shift toward non-classical and intermediate populations. For any assay that depends on a specific monocyte subtype, that shift is not recoverable by any downstream protocol step.
The 30-Minute Standard: What Happens Between Collection and Cryopreservation
OrganaBio processes all leukapheresis collections within 30 minutes of receipt at each site. The protocol from collection completion to cryopreservation:
Step 1: Receipt and Inspection (0–5 minutes)
The leukapheresis product is received from the apheresis technician and visually inspected. Volume, color (pink-to-red tint is acceptable; significant hemolysis is not), and absence of clotting are verified. Weight is recorded. The time of collection completion and time of receipt are logged on the lot record — the source document for the processing time claim on the lot release certificate.
Step 2: Dilution and Density Gradient Setup (5–15 minutes)
The leukapheresis product is diluted in phosphate-buffered saline and layered over density gradient medium (Ficoll-Paque or equivalent). The volume and density gradient are calibrated to the lot volume. Centrifugation begins within 15 minutes of receipt at most OrganaBio sites, within 10 minutes at high-volume sites.
Step 3: PBMC Harvest and Washing (15–40 minutes post-centrifugation)
The buffy coat interface is collected, transferred to fresh medium, and washed twice to remove residual density gradient medium, red blood cells, and platelets. Cell count and viability are measured by automated cell counter (NucleoCounter or equivalent). Each wash step is performed at reduced speed (300–400 × g) to minimize lymphocyte activation from centrifugation shear.
Step 4: Quality Check Before Cryopreservation
Before cells go into cryoprotectant, OrganaBio performs a pre-freeze quality check:
- Total nucleated cell count and viability (target ≥85% viability)
- Differential count: lymphocyte, monocyte, and granulocyte percentages
- Flow cytometry panel: CD3 (T cells), CD4, CD8, CD19 (B cells), CD14 (monocytes), CD56 (NK cells)
- CD4:CD8 ratio (critical for CAR-T starting material qualification)
Lots that fail any acceptance criterion are rejected before cryopreservation. A lot that passes is the only lot that enters inventory. This is documented on the lot release certificate.
Step 5: Cryopreservation
Cells are resuspended in cryoprotectant medium (typically 10% DMSO in human AB serum or a serum-free equivalent) at the target cryopreservation density (typically 20–50 × 10⁶ cells/mL). Aliquots are filled into cryovials, loaded into a controlled-rate freezer, and cooled at −1°C/minute to −80°C before transfer to liquid nitrogen vapor phase storage (−150°C or below). From receipt to frozen: total elapsed time target is under 3 hours for standard processing lots, under 2 hours for priority lots at high-volume sites.
Why Same-Day Processing Cannot Be Replicated by Next-Day or Shipped Samples
Some suppliers ship whole blood or leukapheresis products overnight for central processing. The shipping model has specific biology consequences:
Temperature variation during transit. Even in temperature-controlled shippers, leukapheresis products experience temperature fluctuations above 4°C during transfer between phases (donor site to shipper, shipper loading dock to aircraft, transit, unloading). Each fluctuation above 4°C accelerates cell activation and cytokine release.
Cell-to-cell contact time. PBMCs held in whole blood or unprocessed leukapheresis medium are in direct contact with activated monocytes and platelets for the duration of transit. This contact drives T cell activation, CD25 upregulation, and cytokine production that does not reverse after processing.
Time to cryopreservation. A leukapheresis product processed 18–24 hours after collection accumulates activation artifacts that cannot be washed away. Functional assay results from these samples differ meaningfully from same-day processed material — a fact that OrganaBio’s network model was built specifically to prevent.
OrganaBio’s Processing Network: How Geography Eliminates Transit Time
OrganaBio operates processing facilities co-located with or adjacent to apheresis collection sites in Miami, Irvine, Hayward, and San Diego. This co-location is the structural choice that makes the 30-minute standard achievable at scale. The alternative — collecting in multiple cities and shipping to a single central processing facility — would require compromising either the processing time standard or the geographic collection coverage. OrganaBio chose not to make that compromise.
For clinical trial sponsors requiring consistent starting material across multiple collection sites: the co-located processing model means that a leukapheresis collection in Miami and a collection in Hayward both reach OrganaBio’s processing laboratory in under 30 minutes. The same-day processing guarantee is not site-specific — it applies across the network.
What the 30-Minute Standard Means on the Lot Release Certificate
Every OrganaBio lot release certificate includes:
- Time of leukapheresis completion (from apheresis center record)
- Time of first processing step (receipt at OrganaBio facility)
- Time of cryopreservation
- Pre-freeze and post-thaw viability measurements
The collection-to-processing interval is a documented, verifiable data point — not a marketing claim. For IND submissions and GMP process documentation where time-from-collection is a manufacturing variable, this audit trail provides the source data. Contact the scientific team to discuss lot release documentation standards for your program.
